Skip to content
1634-Evolution of T-Prolymphocytic Leukemia Progression episode artwork

Oct 1, 2026 16 min

1634-Evolution of T-Prolymphocytic Leukemia Progression

from Paper Talk

This study utilizes single-cell genomics and whole genome sequencing to investigate the molecular evolution of T-prolymphocytic leukemia (T-PLL) as it transitions from an indolent to an active stage. By analyzing longitudinal patient samples, researchers identified that disease progression is driven by the upregulation of MYC-target gene signatures and a significant increase in energy metabolism, specifically oxidative phosphorylation and glycolysis. The findings also highlight a loss of T-cell receptor signaling importance and a reduction in interactions with the tumor microenvironment, suggesting that leukemic cells gain autonomy from external growth signals. Furthermore, the data point toward the clonal expansion of ATM-deficient cells and the accumulation of MYC copy number gains as key genomic events. Ultimately, this research provides a comprehensive transcriptomic atlas that reveals shared mechanisms of tumor evolution, offering potential new avenues for targeted therapeutic interventions in an otherwise treatment-resistant cancer. References: Wahnschaffe L, Jungherz D, Müller T A, et al. Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression[J]. Nature Communications, 2026, 17(1): 2319. 前往小宇宙评论区与主播互动

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

1634-Evolution of T-Prolymphocytic Leukemia Progression

0:00 16:38

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Paper Talk?

This episode is 16 minutes long.

When was this Paper Talk episode published?

This episode was published on October 1, 2026.

Can I download this Paper Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.